RBC Capital Sticks to Their Buy Rating for KP Tissue

By Ryan Adsit

The Consumer Goods sector company, KP Tissue (TSX: KPT), has received a rating update from a Wall Street analyst on November 13. Analyst Paul Quinn from RBC Capital remains bullish on the stock and has a C$17 price target.

According to TipRanks.com, Quinn is a top 25 analyst with an average return of 21.5% and a 79.5% success rate. Quinn covers the Consumer Goods sector, focusing on stocks such as Rayonier Advanced Materials, Mercer International Inc, and International Paper Co.

Currently, the analyst consensus on KP Tissue is Strong Buy and the average price target is C$17.25, representing a 24.5% upside.

In a report issued on November 8, Scotiabank also maintained a Buy rating on the stock with a C$17.50 price target.

KP Tissue’s market cap is currently C$127.2M and has a P/E ratio of 0.

KP Tissue, Inc. operates as a holding company. The company produces, distributes, markets and sells disposable tissue products, such as bathroom tissue, facial tissue and paper towels for both the consumer and away-from-home markets. KP Tissue was founded in October 2012 and is headquartered in Mississauga, Canada.

The company’s shares closed on Tuesday at C$13.85.